➡️ Get My 3 Free AI Stock Alerts Before the Market Opens Trading is risky, results are not typical. Full disclaimer.
GPSM | Will Bell |
On Main Street We Say..., "If It's Not Making Dollars, well..."
It's Not Making CENTS:
Discover Our Top 5 Companies for Your 2026 Stock Watchlist!
Before you view this watchlist, grab your subscription to the Golden Penny Stock Millionaires Trading Newsletter.
You can access research on penny stocks that have historically demonstrated high-velocity price action. While past moves do not guarantee future results, we focus on identifying these catalysts before the broader market reacts.
Click Here to Order Your Subscription...
...once you are subscribed, you'll get weekly penny stock alerts.
👉 You'll also learn my trading rules, my chart patterns, and best trading practices which I learned the hard way over 20 years of trading stocks.
Now that you have your subscription...
...and despite the fact that meme stocks are on their way out, here are the 5 penny stocks that I found that have the potential to rise.
My Top 5 Penny Stock To Watch Throughout 2026:
1.Nuvation Bio Inc. (NASDAQ: $NUVB$ Get my report here)
2.Globalstar (NYSEAMERICAN: $GSAT$ Get my report here)
3.VAALCO Energy (NASDAQ: $EGY$ Get my report here)
4.Senseonics (NYSEAMERICAN: $SENS$ Get my report here)
5.GERON CORP (NASDAQ: $GERN$ Get my report here)
These Are The Penny Stocks I'm Keeping An Eye On For Strong Bullish Price Action Before The EOY '26 And Here's Why.
"Remember that you are not required to trade every day. Develop the patience to wait for the best possible setups."
Far too many traders take random setups, which result in random results.
Take your time guys.
My Penny Stock List For 2026 #1: Nuvation Bio Inc. $NUVB$
Nuvation Bio Inc. is a global oncology company.
Nuvation Bio Inc, is dedicated to developing innovative oncology therapies, with a particular emphasis on tackling hard-to-treat cancers.
Nuvation Bio is a global oncology company that reached a major turning point in 2025 by evolving from a clinical-stage developer into a commercial-stage organization. They are focused on some of the toughest challenges in cancer treatment, specifically hard-to-treat solid tumors.
Key 2026 Catalysts & Milestones:
-
Commercial Success of IBTROZI®: On June 11, 2025, the FDA approved Nuvation's lead asset, taletrectinib (now marketed as IBTROZI®), for the treatment of advanced ROS1-positive non-small cell lung cancer (NSCLC). By the start of 2026, the drug has seen rapid adoption, reporting $24.7 million in net revenue within its first six months of launch.
-
Global Expansion with Eisai: In January 2026, Nuvation inked a massive exclusive licensing deal with Eisai Co., Ltd. to bring IBTROZI® to Europe and other major international markets. This deal provided Nuvation with a $60 million upfront payment and potential milestones totaling roughly $230 million, significantly strengthening their balance sheet.
-
The AnHeart Acquisition: The all-stock acquisition of AnHeart Therapeutics (completed in Q2 2024) was the strategic move that brought taletrectinib into Nuvation’s portfolio. This merger transformed the company's valuation and provided the bridge to their current commercial success.
-
Phase 3 Pipeline Progress: Beyond lung cancer, Nuvation is aggressively moving forward with safusidenib. In February 2026, they finalized a protocol amendment to expand the SIGMA trial into a Phase 3 study for IDH1-mutant glioma, targeting an area with zero approved targeted therapies.
The Bottom Line for 2026:
With over $529 million in cash reported at the end of 2025 and a growing revenue stream from IBTROZI®, Nuvation Bio is no longer "hoping" to commercialize - they are actively scaling. Keep a close eye on their international regulatory filings in Europe throughout the first half of 2026.
My Penny Stock List For 2026 #2: Globalstar $GSAT$
Globalstar is one of the year-end 2026 penny stocks with tremendous upside potential ($GSAT$)
Globalstar has moved far beyond the "speculation phase" and is now a critical infrastructure provider for the Direct-to-Device (D2D) revolution. While once seen as a struggling satellite operator, $GSAT$ is now a central player in the global connectivity war between Apple and SpaceX.
Key 2026 Catalysts & Milestones:
-
The Apple Expansion: In late 2024 and throughout 2025, Apple significantly deepened its commitment to Globalstar, investing an additional $1.5 billion to expand satellite messaging and "Apple Intelligence" connectivity. This deal effectively secures Globalstar’s revenue through the end of the decade.
-
SpaceX Launch Partnership: Proving that "competitors can be partners," Globalstar signed multiple launch service agreements with SpaceX. In June 2026, a SpaceX Falcon 9 is scheduled to launch the next set of C-3 satellites, part of an upgrade plan that Apple has reportedly funded up to 95%.
-
Asset Value & Buyout Buzz: By January 2026, institutional analysts have begun valuing Globalstar’s "hidden assets"—specifically its globally harmonized S-band spectrum—at significantly higher levels. Rumors of a $10 billion+ buyout by either SpaceX or a major carrier have kept the stock’s floor high, with some analysts setting price targets as high as $62.00 to $75.00 as it transitions out of penny stock territory.
-
Global Infrastructure Growth: In early 2026, Globalstar completed a major expansion of its ground stations, including the installation of three new C-3 tracking antennas in South Korea. This expands their reach into the high-growth East Asian IoT and 5G markets.
The Bottom Line for 2026:
The "Apple Rumor" is now a confirmed multi-billion dollar revenue stream. With the C-3 constellation launch on the horizon for mid-2026 and SpaceX now acting as their primary "delivery truck" to orbit, $GSAT$ has transformed from a speculative play into a strategic infrastructure asset.
My Penny Stock List For 2026 #3: VAALCO ENERGY $EGY$
VAALCO Energy is an independent oil and gas exploration and production company headquartered in Texas. It focuses on properties in West and North Africa and western Canada.
Key 2026 Catalysts & Milestones:
-
The Great Canadian Exit: In February 2026, VAALCO announced a deal to sell its non-core Canadian assets for approximately $25.6 million (USD). This move streamlines the company, allowing management to focus entirely on its high-margin production in Gabon, Egypt, and Côte d'Ivoire.
-
Sustainable 5% Dividend Yield: While your previous notes mentioned a 6% yield, the stock's 2026 rally to the $4.70–$5.00 range has normalized the yield to a still-impressive 5.2%. VAALCO has maintained a steady $0.25 annualized dividend, a rare feat for a company often priced at penny-stock levels.
-
Production Growth & New Wells: VAALCO started 2026 with strong momentum, reporting 2025 sales at the top end of their guidance (22,100 BOEPD). They are currently drilling the ET-15P horizontal well in Egypt, which is expected to go into production by the end of Q1 2026.
-
Strong Debt-Free Balance Sheet: As of January 2026, the company increased its cash position to nearly $59 million with zero debt drawn against its reserve-based lending facility. This financial health provides a "safety floor" that many other small-cap energy stocks lack
The Bottom Line for 2026: VAALCO is a "Value Play" hiding in a "Penny Stock" wrapper.
By divesting from Canada and focusing on high-margin African oil, they are positioning themselves for a potential re-rating. Keep an eye on the ET-15P production numbers in March 2026 - if the flow rates exceed expectations, the stock could finally break its 52-week resistance at $5.38.
My Penny Stock List For 2026 #4: Senseonics Holdings, Inc ($SENS$)
Senseonics Inc. is a penny stock with tremendous growth potential ($SENS$)
Senseonics is no longer just a "meme stock" favorite; it has solidified its place as a leader in medical infrastructure for long-term diabetes management. The company’s "One Year, One CGM" mission became a reality in late 2024 and is driving their 2026 revenue.
Key 2026 Catalysts & Milestones:
-
Eversense® 365 Global Rollout: Following its FDA approval in September 2024, the world’s first and only 365-day CGM system officially launched across the U.S. in late 2025. In January 2026, Senseonics reached another massive milestone by receiving CE Mark approval, clearing the way for a launch in Germany, Italy, Spain, and Sweden throughout the first half of this year.
-
First Commercial AID Integration: In January 2026, Senseonics and Sequel MedTech treated the first commercial patients using the twiist™ Automated Insulin Delivery (AID) system paired with the Eversense 365 sensor. This makes it the first AID system in the world integrated with a one-year CGM, a major competitive edge over short-term sensors.
-
Commercial Independence: As of January 1, 2026, Senseonics has taken full ownership of its global sales and marketing, transitioning away from its previous distribution partnership. This shift is expected immediately to improve gross margins, with management targeting 50% margins in 2026.
-
Rapid Patient Growth: Driven by the 365-day launch, Senseonics reported a 160% increase in new U.S. patient growth in late 2025. With a "universal shelf" of $300 million in potential capital filed, the company is well-funded to scale its commercial operations through the end of 2026.
The Bottom Line for 2026:
Senseonics has "graduated" from a 180-day niche player to a global 365-day powerhouse. The integration with the twiist™ pump is a game-changer for 2026. Watch for the Q1 2026 earnings report in March - if the European launch and AID integration show strong early numbers, $SENS$ could finally break out of its long-term range.
My Penny Stock List For 2026 #5: GERON Corp. ($GERN$
Geron has successfully transitioned from a decades-long R&D story into a commercial powerhouse in the blood cancer space. With its flagship drug, RYTELO™ (imetelstat), now approved in both the U.S. and the European Union, the company is entering its most critical revenue-scaling year.
Key 2026 Catalysts & Milestones:
-
2026 Revenue Guidance: In January 2026, Geron provided official financial guidance, projecting RYTELO™ net product revenue between $220 million and $240 million for the year. This represents massive top-line growth as the drug becomes the standard of care for lower-risk MDS patients with transfusion-dependent anemia.
-
The "IMpactMF" Interim Analysis: This is the big one for 2026. Geron expects an interim analysis readout for its Phase 3 IMpactMF trial in the second half of 2026. This trial is evaluating RYTELO™ for relapsed/refractory Myelofibrosis (MF), a "disease-modifying" opportunity that could significantly expand their addressable market.
-
EU Commercial Launch: Following European Commission approval, Geron is initiating the commercial launch of RYTELO™ in select European markets throughout 2026. This provides a second major revenue stream and diversifies their geographical footprint.
-
Strategic Restructuring: In late 2025, Geron completed a strategic restructuring to reduce operating expenses. Management expects the company to reach a "sustainable" financial position by the second half of 2026, as revenue growth begins to outpace operating spend.
The Bottom Line for 2026:
Geron is currently a "show me" story that is actually starting to show the numbers. While the stock has seen volatility, the $220M–$240M revenue target for 2026 provides a concrete valuation floor. If the IMpactMF interim data in H2 2026 is positive, $GERN$ could finally break its long-term resistance and trade well above the "penny stock" range.
If this is the starting point of your investing journey... there is hope my friend if you can shift your focus from
making money to learning the markets.
Money truly is the end game to most folks...
... a way to obtain freedom, which freedom for me is surfing the Emerald Coast when I want.
_edited.jpg)
Are you new to penny stocks? Begin by reading my FREE penny stock guide here.
Also, you can get my book "The Legendary Rules To Trading Penny Stocks" for free right here.
Read "Signs Of A True And False Range Breakout" to learn the fundamentals of my strategies.
And if you believe you have what it takes to trade small-cap,
*** Start Your Subscription *** To My Penny Stock Trading Newsletter Golden Penny Stock Millionaires and start getting access to my weekly watchlist.
Only grab your subscription if you are prepared to put in the work on the online trading floor.
*** Join Golden Penny Stock Millionaires Today ***
Subscribers also get access to best trading practices on each trade with the catalyst behind every trade. If you're still undecided about trading with GPSM Stock Alerts Click Here to see what some of our subscribers say.
Why Should You Consider Penny Stocks As A Trading Tool For Your Wealth?
"Penny stocks are prone to scams," as you've probably heard and seen in the movies like The Wolf of Wall Street.
Perhaps even your financial advisor advised you that "penny stocks are a very high-risk investment."
Well, folks here are the facts I've come to terms with over 20 years of trading penny stocks and Big-Caps...
Penny stocks are NOT suitable for long-term investments. It's like raising a family in a Hotel vs a House.
A ton of penny stock companies fail or reinvent themselves and pivot to whatever is hot (like NFTs) and get a short-term spike. Most of these companies don't have enough cash for their daily operations.
But that is what makes penny stocks so appealing.
Others consider penny stocks to be investments. To put it another way, they buy into the ultra hype and rewards do come.
In The Art Of War for penny stock investing, however... those traders generate massive volatility for small-caps which focus our trading system to focuses on high-probability setups where the technical indicators align 7 out of 9 times before a volatility spike."
The best part is that you can use learn to identify common patterns of profits too. Then it's just a matter of discovering which ones will be supernovas...
How to Pick the Best Penny Stocks to Trade
We created our penny stock Signal Alerts to to structure trades using predefined criteria.
Having said that, members would still email always, and ask how we go about selecting stocks.
A list of all penny stocks on just the OTC would take you days to sift through.
Even a list of the top 100 penny stocks would be insufficient. You must delve deeper.
Here's a smart tip to get started.
-
Look for stocks that have experienced significant recent price movement
This has always been a key factor for winners.
I'm interested in boring stocks too, at times...just ask my wife - (like drinking the milk from my cereal bowl while dining at a 5-star Steakhouse), especially when it comes to Growing a Small Account.
Golden Penny Stock Millionaires Trading Newsletter includes a number of possible big percent gainers in the watch list which is issued before the Opening Bell.
Make use of it.
Examine The Exchange
This is critical, especially for a beginner traders... OTC stocks do not trade before or after market hours. That's great news for newcomers.
Furthermore, when it comes to OTCs, Level 2 data is more important. It becomes more difficult to use Level 2 once you begin trading high-volume listed stocks.
Finally, some OTC penny stocks are labeled as Pink Limited these have high risk / high reward plays. Some are even labeled buyer beware.
Be cautious of these stocks. I'm not saying never trade them, just be cautious.
Check Out The Company's History
You'll probably no longer need to do this after a while.
Why?
Because you'll understand the nature of the beast you hunt when trading online." Some penny stock companies change their names or industries as frequently as we change cars.
Always Double-Check Their Claims.
The following step is to seek out a catalyst. The majority of big percent gainers move in response to the news.
This is critical...
Take a press release, or a penny stock company tweet lightly. Make an effort to verify how true what the company said is.
Remember folks "No one gets fired for buying IBM" but you're not trading IBM's Stock.
Again, the majority of these penny stock businesses don't have
-
Any Products
-
No Revenues
-
And half of the time, no money for daily operating costs
They will, however, continue to issue press releases about their
-
"World-Changing Technology."
-
Large Contract
-
New Gold Mine,
-
Oil Well, or
-
Metaverse Property.
The majority of it is loose change, and I say that because if you believe the hype and trade on that... it's the value of what your trading account will amount to.
Loose Change -
- While other traders' accounts are valued at over a million dollars
So as a result, you should never believe the product hype.
Instead… Just keep an open mind.
That is true regardless of what free newsletters, promoters, or cheerleaders tweet or what you hear in a Discord chat.
After you've been burnt on profits you'll understand why 20-year vets in this industry like myself follow a certain set of rules with discipline when it comes to trading penny stocks.
Think Of It This Way...
...The forces of "Heavier Than Air Flight" were on the earth 4,239 years ago - [lift, weight, thrust, and drag], but no human being observed them in those years, so no one flew, except birds and winged things.
Yet, those same forces, and laws, of flight governed the earth at that time, and in the 1900s when we once observed those same laws we achieved flight...
...you see they've always been there...
...the same Market Forces that govern penny stocks in the Boiler Room and Bucket Shop years of the 1900s, are the same Market Forces that govern penny stocks online today.
👉 Nothing has changed... just you were born.
That is why it was critical for us to include this level of wisdom in the DNA of our investing ecosystem when we created our penny stock trading newsletter Golden Penny Stock Millionaires in 2012.
It's not just about making money, but keeping it.
This saves you hours of research time spent sifting through so-called due diligence, game players, pump and dumps, etc.
Without a trusted and proven trading newsletter like Golden Penny Stock Millionaires setting the standard, if you're new to the online world of penny stocks...
...I would think 11 times over about taking a trade. Don't sacrifice your money, instead increase your trading education.
Repeat Successful Winning Techniques & Add Penny Stocks To Your Watch List.
That's where you start guys.
Repeat the process to add more stocks to your watchlist.
Every day you'll have to do Watchlist Maintenance.
Remove one or two items from the list, or move them to a secondary list. Then, with a catalyst and volume, combine the day's top percent gainers.
Ready To Start Trading Penny Stocks?
If so, here's what I want you to do next -
Click Here to access your subscription to our Golden Penny Stock Millionaires™ research system and get 2-3 Weekly Penny Stock Alerts with Entry & Exit Price Points, Trading Strategies, and Market insights for NYSE/NASDAQ penny stocks.